We suggest that although the anti-FXa test should be used to dose LMWH’s in patients with unpredictable pharmacokinetics: children, the obese, those in renal failure; more functional tests of anticoagulation are required to monitor the actual effect of these drugs [18,19]. Here, F10 is linked to Renal insufficiency.